A double-blind, randomized, placebo-controlled trial of adjunctive blue-blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder.
Yuichi EsakiIpei TakeuchiSoji TsuboiKiyoshi FujitaNakao IwataTsuyoshi KitajimaPublished in: Bipolar disorders (2020)
Although concurrent medications may have influenced, our results suggest that BB glasses may be useful as an adjunctive treatment for circadian rhythm issues in patients with BD.